MDGL Crossed $100 Mark, INSY Awaits FDA Decision In July, ODT IPO Today
Dec 7, 2017 - RTT News

Today's Daily Dose brings you news about Edwards' recent acquisition; FDA decision date for Insys' NDA; Madrigal's NASH trial results; private grant funding for Moleculin's brain tumor drug candidate and Vistagen's patent for MDD drug candidate. Read on… Edwards Lifesciences Corp. (EW) has acquired privately held medical technology company Harpoon Medical … (continue reading)

Would you like to track this news?

Click one of the buttons below or search.

Advanced Options | Search Tips